Arthritis Clinical Trials in Massachusetts

39 recruiting studies across 1 city

Browse by City

All Trials in Massachusetts

Phase

Trial	Phase	Sponsor	Dist.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	Phase 1	National Cancer Institute (NCI)	<1 mi
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study	—	Brigham and Women's Hospital	<1 mi
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout	Phase 4	Massachusetts General Hospital	<1 mi
The Osteoarthritis Prevention Study	N/A	Wake Forest University	<1 mi
Multi-Center PAMPA Study	Phase 4	NYU Langone Health	<1 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)	Phase 1	UCB Biopharma SRL	<1 mi
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis	Phase 1	Sonoma Biotherapeutics, Inc.	<1 mi
Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares	Phase 4	Massachusetts General Hospital	<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	<1 mi
Remote Tai Chi for Knee Osteoarthritis	N/A	Tufts Medical Center	<1 mi
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.	N/A	Aptis Medical	<1 mi
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear	—	Massachusetts General Hospital	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases	Phase 2	Amgen	<1 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic	—	Sonoma Biotherapeutics, Inc.	<1 mi
Turmeric for Patients With Basal Joint Arthritis	N/A	Massachusetts General Hospital	<1 mi
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies	Phase 3	Massachusetts General Hospital	<1 mi
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	<1 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Phase 3	Vor Biopharma	<1 mi
Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment	Phase 2	Brigham and Women's Hospital	<1 mi
SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial	Phase 4	Massachusetts General Hospital	<1 mi
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA	Phase 2	Massachusetts General Hospital	1 mi
Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis	N/A	Massachusetts Institute of Technology	3 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	4 mi
Sleep TO Prevent Post-surgical Pain	N/A	Johns Hopkins University	6 mi
A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)	—	Smith & Nephew, Inc.	8 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	8 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	9 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	9 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	9 mi
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain	Phase 2	Eli Lilly and Company	9 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	25 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	39 mi
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA	—	Brown University	41 mi
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis	Phase 3	Rhode Island Hospital	41 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.